METHODS

Literature inclusion criteria and exclusion criteria:
All the included studies must meet the following criteria: (1) Type of study: case-control or cohort studies; (2) content of study: LOXL1 gene polymorphisms and POAG susceptibility; (3) data: studies providing genotype and allele frequencies. We excluded studies that 1) provided incomplete data and that cannot be used to extract genotype and allele frequencies; 2) presented unreliable genotyping methods; 3) published repeated data from the same study.
Identification and eligibility of relevant studies:
To identify all articles that examined the association of LOXL1 polymorphisms with POAG, we conducted a literature search of the PubMed, EMBASE, CNKI, Wanfang, and VIP databases until February 2014 using the following MeSH terms and keywords: "LOXL1" of "lysyl oxidase-like 1"; and "polymorphism" or "SNP" or "mutation"; and "primary open angle glaucoma" or "POAG." Additional studies were identified by a manual search of references from original studies or review articles on this topic.
Statistical methods: Revman 5.2 statistical software was used to perform the meta-analysis. The odds ratios (OR) of the genetic LOXL1 polymorphisms were combined and calculated, the 95% CIs were calculated, and the forest plots of the OR value distributions were drawn. Statistical heterogeneity was performed using an I 2 test analysis. If I 2 <50%, all the included studies had no significant statistical heterogeneity regarding OR quantity. The fixed effects model was adopted, . Forest plot of the association of POAG with rs1048661 in the total population; the horizontal lines correspond to the studyspecific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight.
The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixed-effects model was used.
and the random effects model analysis was used if the status was conversed.
RESULTS
Literature inclusion:
As shown in Figure 1 , the relevant databases were reviewed and 132 literatures were found to meet the inclusion criteria for the meta-analysis. Of the 132, 119 literatures were excluded due to duplicated publications, non-clinical-based research, or non-availabilities of full texts. In total, 13 literatures [12,19-30,] were included, all of which were case-control studies totaling 5,293 subjects. The characteristics of the included studies were shown in Table 1 .
Meta-analysis:
All the publications including these three SNPs showed no significant heterogeneity (rs2165241: I 2 = 43%, p = 0.07; rs1048661: I 2 = 16%, p = 0.29; rs3825942: I 2 = 0%, p = 0.48), Therefore, the data were combined using the fixed effects model. For rs2165241, the meta-analysis results showed that the risk of POAG in individuals carrying the C allele was 1.26 times compared to those carrying the T allele (OR = 1.26, 95% confident interval (CI): 1.09 ~1.46, p = 0.002) in the total population (Figure 2 ). In the Caucasian population, we found that individuals carrying the C allele of rs2165241 have an increased risk for POAG compared to those subjects carrying the T allele (OR = 1.42, 95% CI: 1.19 ~1.69, Figure 5 . Forest plot of the association of POAG with rs3825942 in the total population; the horizontal lines correspond to the studyspecific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight. The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixed-effects model was used. Figure 6 . Forest plot of the association of POAG with rs1048661 in the Caucasian and Asian populations; the horizontal lines correspond to the study-specific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight. The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixedeffects model was used. p = 0.0001). However, we found no association in the Asian population (p = 0.64, Figure 3 ).
For rs1048661 and rs3825942, we found no associations between the genotype or allele and POAG in the total population ( Figure 4 and Figure 5 ). However, we found that the rs1048661 polymorphism was associated with POAG in the Asian population (OR = 1.17, 95% CI: 1.02 ~1.35, p = 0.03, Figure 6 ), and rs3825942 was associated with POAG in the Caucasian population (OR = 2.69, 95% CI: 1.61 ~4.47, p<0.001, Figure 7 ).
Publication bias analysis:
We analyzed the publication bias using Revman 5.2 software; the funnel plot shows the points as evenly distributed and symmetric, and most of the points are within the 95% CI. This indicates no publication bias, and the result of the study is credible (Figure 8) .
DISCUSSION
In the present study, 13 literatures were included in a metaanalysis to investigate the relationship between the LOXL1 gene polymorphisms and POAG. The results showed that the genetic polymorphisms of LOXL1 were associated with a risk of POAG.
LOXL1 is located on human chromosome 15q22, and it is a member of the lysyl oxidase family [31] , members of which can encode a kind of copper-dependent amino oxidase. This enzyme acted on the cell, and it catalyzes the first step of the Figure 7 . Forest plot of the association of POAG with rs3825942 in the Caucasian and Asian populations; the horizontal lines correspond to the study-specific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight. The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixedeffects model was used. cross-linking reaction between collagen and elastin [32] . The gene-encoded protein is a secreted protein; after that, it is synthesized in the form of a precursor, and it is glycosylated in the Golgi complex and secreted out of the cells in the plasminogen state. Under the action of the proteolytic enzymes, LOXL1 can convert to an active form and act on the elastic and collagen fibers in the extracellular matrix. LOXL1 expression upregulation and abnormally high levels of enzyme activity can cause excessive collagen accumulation and result in the occurrence and development of related diseases, such as POAG. The rs2165241 of the LOXL1 gene is located in the coding region of the gene. Thus, the polymorphism may be associated with the expressed products. The LOXL1 protein encoded by the C allele is different from the protein encoded by the T allele in the primary and spatial structures [12] , which will result in changes to the biologic function of the protein, and it will eventually result in different incidences of POAG in individuals carrying different alleles. The other two SNPs (rs1048661 and rs3825942) are non-synonymous variants, which may affect protein function or expression. In the present study, we used meta-analysis methods to investigate the relationships between these three SNPs in the LOXL1 gene and POAG, which has certain advantages. We found that in the Caucasian population, individuals carrying the C allele of rs2165241 have an increased 1.42-fold risk for POAG compared to those subjects carrying the T allele. In addition, we found that the rs1048661 polymorphism was associated with POAG in the Asian population and rs3825942 was associated with POAG in the Caucasian population. We found neither heterogeneity nor a publication bias among the studies. In addition, the sensitivity analysis showed that the results were stable and reliable. In conclusion, the present study indicated that LOXL1 genetic polymorphisms are associated with susceptibility to POAG.
